Hosted on MSN
Long Shortz with Race Oncology: Understanding the mechanism of action that could transform cancer therapy
Host Tylah Tully sits down with Race Oncology (ASX:RAC) CEO Daniel Tillett to discuss the groundbreaking discovery of the primary mechanism of action of their lead drug. Tillett explains how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback